Kanabo Group PLC

Research Kanabo Group PLC (KNB) on Bullrun: market cap GBX 1.39M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerKNB
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryMedical Care Facilities
• CurrencyGBX
• Market capGBX 1.39M
• Financial periodFY2023
• RevenueGBP 895.00K
• Revenue growth48.4%
• Net income-GBP 7.99M
• Free cash flow-GBP 3.05M
• Gross margin15.0%

Valuation Snapshot

latest market cap is GBX 1.39M.

About Kanabo Group PLC

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.

Frequently asked questions

What is Kanabo Group PLC's market cap?

Kanabo Group PLC's market capitalization is GBX 1.39M.

What does Kanabo Group PLC do?

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments.